Uniqure

Uniqure

Yahoo Finance • 3 days ago

Spyre Therapeutics (SYRE) Down 16.6% Since Last Earnings Report: Can It Rebound?

A month has gone by since the last earnings report for Spyre Therapeutics (SYRE). Shares have lost about 16.6% in that time frame, underperforming the S&P 500. But investors have to be wondering, will the recent negative trend continue le... Full story

Yahoo Finance • 4 days ago

UniQure's Embattled Huntington's Gene Therapy Clears A Key Hurdle

Uniqure stock wavered Wednesday after the Food and Drug Administration accepted its application for approval of a Huntington's gene therapy. Continue Reading... Full story

Yahoo Finance • 4 days ago

Sirius XM upgraded, Toast downgraded: Wall Street's top analyst calls

Sirius XM upgraded, Toast downgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled... Full story

Yahoo Finance • 9 days ago

Why Is uniQure (QURE) Up 17.5% Since Last Earnings Report?

A month has gone by since the last earnings report for uniQure (QURE). Shares have added about 17.5% in that time frame, outperforming the S&P 500. But investors have to be wondering, will the recent positive trend continue leading up to... Full story

Yahoo Finance • last month

Humana upgraded, Las Vegas Sands downgraded: Wall Street's top analyst calls

Humana upgraded, Las Vegas Sands downgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as c... Full story

Yahoo Finance • last month

Here Are Wednesday’s Top Wall Street Analyst Research Calls: Bloom Energy, Dave, Fiverr, Humana, Las Vegas Sands, Lemonade, Procter & Gamble, SK hynix, Wix.com, and More

Quick Read Iran conflict escalation, oil surging nearly 8%, and a semiconductor sell-off drove the Dow down 2% and Nasdaq down nearly 2% Wednesday. Goldman Sachs cut Fiverr (FVRR) to Neutral and slashed its target in half to $13, while Bl... Full story

Yahoo Finance • last month

uniQure Q2 2026 Earnings Preview

* uniQure (QURE [https://seekingalpha.com/symbol/QURE]) is scheduled to announce Q2 earnings results on Wednesday, July 29th, before market open. * The consensus EPS estimate is -$0.81 [https://seekingalpha.com/symbol/QURE/earnings/est... Full story

Yahoo Finance • 2 months ago

uniQure Announces Pricing of Upsized $225 Million Public Offering

LEXINGTON, Mass. and AMSTERDAM, June 23, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the pricing of its p... Full story

Yahoo Finance • 2 months ago

uniQure Announces $150 Million Proposed Public Offering

LEXINGTON, Mass. and AMSTERDAM, June 22, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that it has commence... Full story

Yahoo Finance • 3 months ago

SpaceX initiated, Salesforce upgraded: Wall Street's top analyst calls

SpaceX initiated, Salesforce upgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compile... Full story

Yahoo Finance • 3 months ago

Top Biotech Gainers: QURE Rallies On AMT-130 Update, LNAI On Track, FTH Eyes Q4 Data, ELTX On Watch

(RTTNews) - Today's top gainers included uniQure, which rallied after the FDA softened its stance on the company's investigational gene therapy; Elicio Therapeutics, following encouraging treatment responses from its cancer vaccine in panc... Full story

Yahoo Finance • 3 months ago

Stocks Retreat as Fed Signals Possible Higher Interest Rates

The S&P 500 Index ($SPX) (SPY) on Wednesday closed down -1.21%, the Dow Jones Industrial Average ($DOWI) (DIA) closed down -0.98%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.99%.  June E-mini S&P futures (ESM26) fell -1.19%, and... Full story

Yahoo Finance • 3 months ago

Stocks Mixed Ahead of FOMC Meeting Results

The S&P 500 Index ($SPX) (SPY) today is down -0.15%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.23%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.30%.  June E-mini S&P futures (ESM26) are down -0.17%, and June E-mini Nasdaq... Full story

Yahoo Finance • 3 months ago

Wednesday Sector Leaders: Computers, Biotechnology Stocks

In trading on Wednesday, computers shares were relative leaders, up on the day by about 5.6%. Leading the group were shares of AstroNova, up about 70.2% and shares of Nano Dimension Ltd (NNDM) up about 9.8% on the day. Also showing relat... Full story

Yahoo Finance • 3 months ago

Stocks Supported by Chip Stock Strength and Strong US Retail Sales

The S&P 500 Index ($SPX) (SPY) today is up +0.23%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.26%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.74%.  June E-mini S&P futures (ESM26) are up +0.19%, and June E-mini Nasdaq fut... Full story

Yahoo Finance • 3 months ago

UniQure, Aehr Test Systems surge premarket; Snap, Leidos fall

Investing.com - U.S. stock futures were broadly steady on Wednesday as investors geared up for a key Federal Reserve interest rate decision and monitored reports on the details of a preliminary Middle East peace agreement. By 08:40 ET (01... Full story

Yahoo Finance • 4 months ago

Considering Uniqure NV (QURE) Stock? Read the AMT-130 Message

Uniqure NV (NASDAQ:QURE) is one of the best gene therapy stocks to buy in 2026. Uniqure shares have gained 60% over the past month and more than doubled over the past year. The Street believes the stock’s rally isn’t done yet and anticipat... Full story

Yahoo Finance • 4 months ago

uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates

~ Advancing FDA interactions on AMT-130 for Huntington’s disease; Type B meeting scheduled for the second quarter of 2026 ~ ~ Progressing AMT-130 toward expected UK regulatory submission; MAA on track for third quarter of 2026 following s... Full story

Yahoo Finance • 4 months ago

UniQure Advances Toward UK Filing For AMT-130 After Positive MHRA Pre-Submission Meeting; Stock Up

(RTTNews) - uniQure N.V. (QURE) said it has completed a successful pre-submission meeting with the UK Medicines and Healthcare products Regulatory Agency (MHRA), clearing the path for a planned Marketing Authorization Application (MAA) for... Full story

Yahoo Finance • 4 months ago

uniQure N.V. (QURE) Stock Posts 30% Growth from Last Year

uniQure N.V. (NASDAQ:QURE) is one of the 10 Best Small-Cap Biotech Stocks According to Hedge Funds. The stock registered a 32.28 percent growth in the past year and a 24.84 percent year-to-date decline.Is uniQure N.V. (QURE) the Most Promi... Full story